Temporal trends in anticoagulation use and clinical outcomes among medicare beneficiaries with non-valvular atrial fibrillation Brett D. AtwaterJennifer D. GuoMauricio Ferri OriginalPaper Open access 02 August 2023 Pages: 1 - 10
Monocyte recruitment in venous pulmonary embolism at time of cancer diagnosis in upper gastrointestinal cancer patients Sarah S. JakobsenJens B. FrøkjaerAnders C. Larsen OriginalPaper Open access 04 October 2023 Pages: 11 - 20
Early assessment of the pharmacokinetic and pharmacodynamic effects following acetylsalicylic acid loading: toward a definition for acute therapeutic response Paul A. GurbelKevin P. BlidenUdaya S. Tantry OriginalPaper Open access 08 December 2023 Pages: 21 - 28
A nomogram to predict ventricular thrombus in dilated cardiomyopathy patients Xiao-Lei LiDilare AdiYi-Tong Ma OriginalPaper Open access 23 June 2023 Pages: 29 - 38
Validating the predictive ability of the 2MACE score for major adverse cardiovascular events in patients with atrial fibrillation: results from phase II/III of the GLORIA-AF registry Wern Yew DingAmeenathul Mazaya Fawzyon behalf of the GLORIA-AF Investigators OriginalPaper Open access 11 August 2023 Pages: 39 - 49
Estimated plasma volume status in COVID-19 patients and its relation to comorbidities and clinical outcomes Marko LucijanicIvan KrecakIvica Luksic OriginalPaper 12 August 2023 Pages: 50 - 57
Higher triglyceride levels are associated with the higher prevalence of layered plaques in non-culprit coronary plaques Kiyoshi AsakuraYoshiyasu MinamiJunya Ako OriginalPaper 13 September 2023 Pages: 58 - 66
EML4-ALK fusion protein in Lung cancer cells enhances venous thrombogenicity through the pERK1/2-AP-1-tissue factor axis Yanping SuJiawen YiYuhui Zhang OriginalPaper Open access 08 November 2023 Pages: 67 - 81
Mechanical pump complication after HeartMate 3 implantation Aurelie MerloPanagiotis TasoudisThomas Caranasos OriginalPaper 04 October 2023 Pages: 82 - 88
Cardiovascular and renal outcomes in patients with atrial fibrillation and stage 4–5 chronic kidney disease receiving direct oral anticoagulants: a multicenter retrospective cohort study Yuan LinTze-Fan ChaoTien-Hsing Chen OriginalPaper 21 August 2023 Pages: 89 - 100
Prevalence of atrial fibrillation and reasons for undertreatment with oral anticoagulants Johan LiljaAnders SjälanderSara Själander OriginalPaper Open access 13 September 2023 Pages: 101 - 106
Digital dashboards for direct oral anticoagulant surveillance, intervention and operational efficiency: uptake, obstacles, and opportunities Darren M. TrillerAaron S. WilsonGeoffrey D. Barnes OriginalPaper Open access 15 October 2023 Pages: 107 - 116
No evidence for a genetic causal effect of breast cancer on venous thromboembolism: a mendelian randomization study Qindan QinYingying PanLi Wang BriefCommunication 24 August 2023 Pages: 117 - 123
Effect of endovascular treatment on patients with basilar artery occlusion presenting with different pathologic mechanisms: a systematic review and meta-analysis Xianjin ShangLiying PanZhiming Zhou ReviewPaper 21 August 2023 Pages: 124 - 131
Effect of statin therapy patterns on readmission and mortality in patients with intracerebral hemorrhage Ruotong YangJunhui WuYonghua Hu OriginalPaper 18 September 2023 Pages: 132 - 142
Optimal anti-platelet therapy for older patients with acute coronary syndrome: a network meta-analysis of randomized trials comprising 59,284 older patients Shuang ZhouWenhui LiYimin Cui OriginalPaper Open access 07 August 2023 Pages: 143 - 154
Low bleeding acceptance is associated with increased death risk in patients with atrial fibrillation on oral anticoagulation Gabriela RusinMałgorzata KonieczyńskaAnetta Undas OriginalPaper Open access 19 August 2023 Pages: 155 - 163
Incidence and factors associated with deep vein thrombosis among hospitalized adult patients at Hawassa university comprehensive specialized hospital Hawassa city, Sidama, Ethiopia: retrospective cohort study Tsegaye AlemuAklilu AduleAsfaw Borsamo OriginalPaper 13 September 2023 Pages: 164 - 174
Pharmacist driven anticoagulation reversal program at a large academic medical center Gabrielle L. ProcopioRuchi P. JainDanielle M. Tompkins Letter to the Editor 29 August 2023 Pages: 175 - 177
Correction: Validating the predictive ability of the 2MACE score for major adverse cardiovascular events in patients with atrial fibrillation: results from phase II/III of the GLORIA-AF registry Wern Yew DingAmeenathul Mazaya Fawzyon behalf of the GLORIA-AF Investigators Correction Open access 09 October 2023 Pages: 178 - 178